{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:25:24Z","timestamp":1787682324688,"version":"build-2784847793"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1124\/jpet.118.249250","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T21:00:10Z","timestamp":1525294810000},"page":"145-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Evidence That Sedative Effects of Benzodiazepines Involve Unexpected GABAA Receptor Subtypes: Quantitative Observation Studies in Rhesus Monkeys"],"prefix":"10.1016","volume":"366","author":[{"given":"Angela N.","family":"Duke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna M.","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Atack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard R.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. V. N. Phani Babu","family":"Tiruveedhula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanguan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Rajesh","family":"Stephen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Sieghart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James K.","family":"Rowlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.118.249250_bib1","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1097\/00000542-200204000-00031","article-title":"Practice guidelines for sedation and analgesia by non-anesthesiologists","volume":"96","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1124\/jpet.118.249250_bib2","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.2174\/156802611795371350","article-title":"GABAA receptor subtype-selective modulators. I. \u03b12\/\u03b13-selective agonists as non-sedating anxiolytics","volume":"11","author":"Atack","year":"2011","journal-title":"Curr Top Med Chem"},{"key":"10.1124\/jpet.118.249250_bib3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/0269881109354928","article-title":"Preclinical and clinical pharmacology of TPA023B, a GABAA receptor &\u03b1;2\/&\u03b1;3 subtype-selective partial agonist","volume":"25","author":"Atack","year":"2011","journal-title":"J Psychopharmacol"},{"key":"10.1124\/jpet.118.249250_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/0269881109354927","article-title":"MRK-409, a GABAA receptor subtype-selective agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in man","volume":"25","author":"Atack","year":"2011","journal-title":"J Psychopharmacol"},{"key":"10.1124\/jpet.118.249250_bib6","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1038\/npp.2016.49","article-title":"A pharmacogenetic \u2018restriction-of-function\u2019 approach reveals evidence for anxiolytic-like actions mediated by \u03b15-containing GABAA receptors in mice","volume":"41","author":"Behlke","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.118.249250_bib7","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.neuropharm.2010.11.026","article-title":"HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic pain","volume":"60","author":"Di Lio","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.118.249250_bib8","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S0022-3565(25)23193-7","article-title":"Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability","volume":"255","author":"Evans","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.118.249250_bib9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00213-010-2142-y","article-title":"Contribution of GABA(A) receptors containing \u03b13 subunits to the therapeutic-related and side effects of benzodiazepine-type drugs in monkeys","volume":"215","author":"Fischer","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.118.249250_bib10","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.neuropharm.2010.08.011","article-title":"Anxiolytic-like effects of 8-acetylene imidazobenzodiazepines in a rhesus monkey conflict procedure","volume":"59","author":"Fischer","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.118.249250_bib12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1021\/jm990341r","article-title":"Pharmacophore\/receptor models for GABA(A)\/BzR subtypes (\u03b11\u03b23\u03b32, \u03b15\u03b23\u03b32, and \u03b16\u03b23\u03b32) via a comprehensive ligand-mapping approach","volume":"43","author":"Huang","year":"2000","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.118.249250_bib13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF02244836","article-title":"Comparison of several benzodiazepine receptor ligands in two models of anxiolytic activity in the mouse: an analysis based on fractional receptor occupancies","volume":"114","author":"Jones","year":"1994","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.118.249250_bib15","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00213-005-0060-1","article-title":"A proof-of-concept study using [11C]flumazenil PET to demonstrate that pagoclone is a partial agonist","volume":"180","author":"Lingford-Hughes","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.118.249250_bib16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1126\/science.290.5489.131","article-title":"Molecular and neuronal substrate for the selective attenuation of anxiety [published correction appears in Science (2000) 290:936c]","volume":"290","author":"L\u00f6w","year":"2000","journal-title":"Science"},{"key":"10.1124\/jpet.118.249250_bib17","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/75761","article-title":"Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor \u03b11 subtype","volume":"3","author":"McKernan","year":"2000","journal-title":"Nat Neurosci"},{"key":"10.1124\/jpet.118.249250_bib19","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/bph.14119","article-title":"Pharmacology in translation: the preclinical and early clinical profile of the novel \u03b12\/3 functionally selective GABAA receptor positive allosteric modulator PF-06372865","volume":"175","author":"Nickolls","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.118.249250_bib20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/(SICI)1098-2345(1998)46:3<213::AID-AJP3>3.0.CO;2-L","article-title":"Effects of puzzle feeders on pathological behavior in individually housed rhesus monkeys","volume":"46","author":"Novak","year":"1998","journal-title":"Am J Primatol"},{"key":"10.1124\/jpet.118.249250_bib21","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/ajp.1350280205","article-title":"Adjustments and adaptations to indoor and outdoor environments: continuity and change in young adult rhesus monkeys","volume":"28","author":"Novak","year":"1992","journal-title":"Am J Primatol"},{"key":"10.1124\/jpet.118.249250_bib22","first-page":"10.5.1","article-title":"Models of neurological disease (substance abuse): self-administration in monkeys","volume":"56","author":"Platt","year":"2011","journal-title":"Curr Protoc Pharmacol"},{"key":"10.1124\/jpet.118.249250_bib23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00213-002-1189-9","article-title":"Selective antagonism of the ataxic effects of zolpidem and triazolam by the GABAA\/\u03b11-preferring antagonist \u03b2-CCt in squirrel monkeys","volume":"164","author":"Platt","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.118.249250_bib25","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1021\/jm801652d","article-title":"Antiseizure activity of novel \u03b3-aminobutyric acid (A) receptor subtype-selective benzodiazepine analogues in mice and rat models","volume":"52","author":"Rivas","year":"2009","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.118.249250_bib27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00213-005-0228-8","article-title":"Anti-conflict effects of benzodiazepines in rhesus monkeys: relationship with therapeutic doses in humans and role of GABAA receptors","volume":"184","author":"Rowlett","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.118.249250_bib28","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1073\/pnas.0405621102","article-title":"Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates","volume":"102","author":"Rowlett","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.118.249250_bib29","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/44579","article-title":"Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes [published correction appears in Nature (2000) 404:629]","volume":"401","author":"Rudolph","year":"1999","journal-title":"Nature"},{"key":"10.1124\/jpet.118.249250_bib38","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrn1496","article-title":"Molecular and neuronal substrates for general anesthetics","volume":"5","author":"Rudolph","year":"2004","journal-title":"Nat Neurosci Rev"},{"key":"10.1124\/jpet.118.249250_bib30","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrd3502","article-title":"Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes","volume":"10","author":"Rudolph","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.118.249250_bib31","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/acer.12018","article-title":"Modulation of \u03b15 subunit-containing GABAA receptors alters alcohol drinking by rhesus monkeys","volume":"37","author":"R\u00fcedi-Bettschen","year":"2013","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1124\/jpet.118.249250_bib32","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/npp.2012.265","article-title":"Reinforcing effects of compounds lacking intrinsic efficacy at \u03b11 subunit-containing GABAA receptor subtypes in midazolam- but not cocaine-experienced rhesus monkeys","volume":"38","author":"Shinday","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/jpet.118.249250_bib34","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.tips.2012.08.003","article-title":"Anxioselective anxiolytics: on a quest for the Holy Grail","volume":"33","author":"Skolnick","year":"2012","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.118.249250_bib35","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.tins.2011.01.004","article-title":"Hooked on benzodiazepines: GABAA receptor subtypes and addiction","volume":"34","author":"Tan","year":"2011","journal-title":"Trends Neurosci"},{"key":"10.1124\/jpet.118.249250_bib36","first-page":"285","article-title":"Zolpidem self-injection with concurrent physical dependence under conditions of long-term continuous availability in baboons","volume":"9","author":"Weerts","year":"1998","journal-title":"Behav Pharmacol"},{"key":"10.1124\/jpet.118.249250_bib37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0091-3057(80)90430-X","article-title":"Drug dependence potential of viloxazine hydrochloride tested in rhesus monkeys","volume":"12","author":"Yanagita","year":"1980","journal-title":"Pharmacol Biochem Behav"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524261851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524261851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.118.249250","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T19:58:29Z","timestamp":1739995109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524261851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0022356524261851"],"URL":"https:\/\/doi.org\/10.1124\/jpet.118.249250","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence That Sedative Effects of Benzodiazepines Involve Unexpected GABAA Receptor Subtypes: Quantitative Observation Studies in Rhesus Monkeys","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.118.249250","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}